Clinical Trial: HucMSCs Exosomes for the Treatment of Active Ulcerative Colitis

U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06853522) titled 'HucMSCs Exosomes for the Treatment of Active Ulcerative Colitis' on Feb. 13.

Brief Summary: To evaluate the safety and efficacy of hUC-MSCs-Exos in the treatment of ulcerative colitis.

Study Start Date: April 04

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis (UC)

Intervention: DRUG: exosomes derived from human umbilical cord mesenchymal stem cells

The corresponding exosome content of 60x10^6 umbilical cord mesenchymal stem cells was given

DRUG: saline +5% albumin

Equal amount of saline +5% albumin was given

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shanghai East Hospital

Published by HT Digital Content Se...